Publikationen von A. Erhardt

Ditzen, C.; Jastorff, A. M.; Kessler, M. S.; Bunck, M.; Teplytska, L.; Erhardt, A.; Krömer, S. A.; Varadarajulu, J.; Targosz, B. S.; Sayan-Ayata, E. F. et al.; Holsboer, F.; Landgraf, R.; Turck, C. W.: Protein biomarkers in a mouse model of extremes in trait anxiety. Molecular & Cellular Proteomics 5 (10), S. 1914 - 1920 (2006)

Erhardt, A.; Ising, M.; Unschuld, P. G.; Kern, N.; Lucae, S.; Holsboer, F.; Keck, M. E.: Responsiveness of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Biological Psychiatry 59 (8 Suppl. S), S. 200S - 200S (2006)

Erhardt, A.; Unschuld, P. G.; Lucae, S.; Ising, M.; Salyakina, D.; Pütz, B.; Müller-Myhsok, B.; Binder, E. B.; Holsboer, F.; Keck, M. E.: Possible genetic implications of the endo-cannabinoid system in anxiety disorders versus depressive disorders. European Neuropsychopharmacology 16 (Suppl. 1), S. S88 - S88 (2006)

Erhardt, A.; Ising, M.; Unschuld, P. G.; Kern, N.; Lucae, S.; Pütz, B.; Uhr, M.; Binder, E. B.; Holsboer, F.; Keck, M. E.: Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Neuropsychopharmacology 31, S. 2515 - 2522 (2006)

Erhardt, A.; Seaman, S. R.; Lucae, S.; Unschuld, P. G.; Kern, N.; Welt, T.; Ising, M.; Salyakina, D.; Pütz, B.; Lieb, R. et al.; Binder, E.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Genetic implications of the endocannabinoid system in anxiety disorders versus depressive disorders: Is there any evidence for the continuum hypothesis? American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 138B (1), S. 44 - 44 (2005)

Kern, N.; Erhardt, A.; Pfennig, A.; Lucae, S.; Ising, M.; Salyakina, D.; Pütz, B.; Müller-Myhsok, B.; Uhr, M.; Holsboer, F. et al.; Binder, E. B.; Keck, M. E.: Syndromal panic attacks are possibly associated with polymorphisms in the angiotensin converting enzyme (ACE) gene. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 138B (1), S. 45 - 45 (2005)

Erhardt, A.; Seaman, S. R.; Lucae, S.; Kern, N.; Unschuld, P. G.; Welt, T.; Ising, M.; Salyakina, D.; Pütz, B.; Lieb, R. et al.; Binder, E. B.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Genetic implications of the endocannabinoid system in anxiety disorders versus depressive disorders: is there any evidence for the continuum hypothesis? Pharmacopsychiatry 38 (5), S. 240 - 240 (2005)

Erhardt, A.; Unschuld, P. G.; Kern, N.; Welt, T.; Ising, M.; Keck, M. E.: Responsiveness of the hypothalamic-pituitary-adrenocortical system in patients with agoraphobia and panic attacks. Pharmacopsychiatry 38 (5), S. 240 - 240 (2005)

Unschuld, P. G.; Ising, M.; Erhardt, A.; Lucae, S.; Welt, T.; Kloiber, S.; Kern, N.; Salyakina, D.; Binder, E. B.; Brückl, T. et al.; Uhr, M.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Polymorphisms in the serotonin receptor gene HTR2A modulate disease severity and susceptibility for anxiety disorders but not depression and are associated with specific personality traits. Pharmacopsychiatry 38 (5), S. 282 - 282 (2005)

Welt, T.; Rödel, A.; Ohl, F.; Erhardt, A.; Keck, M. E.: The explorative-reduced (EXR002) C3H mice - a new mouse model of depression? Pharmacopsychiatry 38 (5), S. 284 - 284 (2005)

Erhardt, A.; Sillaber, I.; Welt, T.; Müller, M. B.; Singewald, N.; Keck, M. E.: Repetitive transcranial magnetic stimulation increases the release of dopamine in the nucleus accumbens shell of morphine-sensitized rats during abstinence. Neuropsychopharmacology 29 (11), S. 2074 - 2080 (2004)

Erhardt, A.; Kern, N.; Knorr, C. C.; Poluda, L.; Thoeringer, C. K.; Unschuld, G.; Salyakina, D.; Pütz, B.; Holsboer, F.; Binder, E. B. et al.; Müller-Myhsok, B.; Keck, M. E.: Possible association of oxytocin and prolactin polymorphisms with panic and anxiety disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 66 - 66 (2004)

Keck, M. E.; Kern, N.; Erhardt, A.; Ising, M.; Unschuld, P. G.; Knorr, C. C.; Poluda, L.; Thoeringer, C. K.; Salyakina, D.; Pütz, B. et al.; Holsboer, F.; Müller-Myhsok, B.; Binder, E.: Interactions of polymorphisms in corticotropin releasing hormone receptor 1 (CRHR1) and vasopressin receptor 1B (V1B) genes predispose for panic disorder. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 64 - 65 (2004)

Kern, N.; Binder, E. B.; Pfennig, A.; Erhardt, A.; Ising, M.; Lucae, S.; Salyakina, D.; Pütz, B.; Holsboer, F.; Müller-Myhsok, B. et al.; Keck, M. E.: Possible association of angiotensin 1 converting enzyme polymorphisms with syndromal panic attacks. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 66 - 67 (2004)

Unschuld, P. G.; Ising, M.; Erhardt, A.; Kern, N.; Lucae, S.; Horstmann, S.; Salyakina, D.; Pütz, B.; Binder, E. B.; Müller-Myhsok, B. et al.; Holsboer, F.; Keck, M. E.: Polymorphisms in serotonin receptor genes HTR1B, HTR2A, HTR2C and HTR4 are possibly associated with specific personality traits in patients suffering from anxiety disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 67 - 68 (2004)

Erhardt, A.; Welt, T.; Rödel, A.; Habersetzer, U.; Stecker, G.; Ohl, F.; Keck, M. E.: Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice - influence of CRH1-receptor antagonism. Pharmacopsychiatry 36 (5), S. 223 - 223 (2003)

Erhardt, A.; Welt, T.; Schmidt, W.; Sillaber, I.; Keck, M. E.: Repetitive transcranial magnetic stimulation (rTMS) increases the release of dopamine in the nucleus accumbens of morphine-sensitized rats during drug-withdrawal. Pharmacopsychiatry 36 (5), S. 223 - 224 (2003)

Kern, N.; Binder, E. B.; Künzel, H. E.; Pfennig, A.; Fuchs, B.; Ising, M.; Erhardt, A.; Lucae, S.; Müller-Myhsok, B.; Modell, S. et al.; Keck, M. E.; Holsboer, F.: Is there a genetic continuum between anxiety and depression? Pharmacopsychiatry 36 (5), S. 239 - 239 (2003)

Keck, M. E.; Welt, T.; Erhardt, A.; Müller, M. B.; Sillaber, I.: Neuroendokrine Effekte der repetitiven transkraniellen Magnetstimulation. Fokus auf Dopamin und Vasopressin. Nervenheilkunde 22 (7), S. 346 - 349 (2003)

Czéh, B.; Welt, T.; Fischer, A. K.; Erhardt, A.; Schmitt, W.; Müller, M. B.; Toschi, N.; Fuchs, E.; Keck, M. E.: Chronic psychosocial stress and concomitant repetitive transcranial magnetic stimulation: Effects on stress hormone levels and adult hippocampal neurogenesis. Biological Psychiatry 52 (11), S. 1057 - 1065 (2002)